Why Dose Comparison Matters for Fast Treatment Starts
Wegovy Dose vs Mounjaro Dose: Next Day Delivery Essentials
When comparing Wegovy dose schedules against Mounjaro dose protocols, delivery speed becomes crucial for maintaining treatment momentum. Wegovy follows a 5-step dose escalation over 16 weeks: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Mounjaro uses a different tirzepatide schedule with 4 main doses over 12 weeks before reaching maintenance. Both require next day cold-chain delivery to preserve the GLP-1 receptor agonist compounds.
EverydayMeds provides temperature-controlled packaging for both medications, ensuring the Wegovy dose vs Mounjaro dose comparison isn't compromised by storage failures. Our tracked delivery system includes signature requirements, as both are prescription-only medicines requiring secure handover. The faster you receive your prescribed dose, the sooner you can begin the structured escalation protocol alongside your reduced-calorie diet and increased physical activity programme.
Wegovy Dose vs Mounjaro Dose: UK Pricing with Express Delivery
Understanding the Wegovy dose vs Mounjaro dose cost implications helps when ordering with next day delivery urgency. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, while returning customers use DOSE25. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing two doses in one next day delivery.
Bundle pricing for the Wegovy dose vs Mounjaro dose comparison shows convenience advantages when ordering multiple pens together. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, covering three escalation steps in one temperature-controlled delivery. Take-It-Slow bundles accommodate those needing extended time at lower doses, such as the Gentle Start Trio at £269.99. All prices include VAT and next day delivery once your clinical assessment receives prescriber approval through our GPhC-registered pharmacy (#9012878).
Clinical Evidence Behind Wegovy Dose vs Mounjaro Dose Protocols
The Wegovy dose escalation protocol demonstrated significant efficacy in the STEP trials, with STEP 1 showing approximately 15% average weight loss at 68 weeks when patients took Wegovy alongside diet and exercise (Wilding et al., NEJM, 2021). STEP 5 maintained approximately clinically studied weight loss over 2 years, supporting the gradual dose increases. The structured approach from 0.25mg to 2.4mg allows gastrointestinal adaptation while maximising the GLP-1 receptor agonist effects.
When evaluating Wegovy dose vs Mounjaro dose clinical foundations, both medications target weight management through different mechanisms - semaglutide works on GLP-1 receptors alone, while tirzepatide combines GIP and GLP-1 pathways. The SELECT cardiovascular outcomes trial showed 20% reduction in major cardiovascular events with Wegovy treatment. However, direct head-to-head comparisons aren't appropriate due to different trial designs and patient populations in the respective clinical programmes.
How Wegovy Works: Understanding the Dose Escalation Science
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for appetite regulation and glucose control. The medication works on specific brain centres that control hunger and satiety, helping you feel full after smaller meals and reducing food cravings throughout the day. Starting with the 0.25mg dose allows your digestive system to adapt gradually to the medication's effects, which include slower gastric emptying and enhanced insulin sensitivity when glucose levels are elevated. The systematic dose increases every four weeks ensure optimal therapeutic benefit while minimising potential gastrointestinal side effects. By the time you reach the 2.4mg maintenance dose, your body has fully adapted to the medication's appetite-suppressing and satiety-promoting effects, supporting long-term weight management goals.
Streamlined Ordering Process for Wegovy Dose vs Mounjaro Dose Decisions
Our online clinical assessment takes just 3 minutes to complete, covering your medical history, current medications, and weight management goals relevant to both Wegovy and Mounjaro prescribing criteria. UK-registered prescribers review your assessment within 3 working days (or 24 hours with express review), determining which dose protocol best suits your individual circumstances and BMI requirements. Once approved, your chosen medication ships via next day delivery in temperature-controlled packaging, maintaining the required 2-8°C cold chain until it reaches your door. The entire process from assessment to delivery typically takes 2-4 working days, ensuring you can start your weight management journey without unnecessary delays. All deliveries require signature confirmation, as both medications are prescription-only medicines requiring secure handover to the named patient.
Storage Advantages in the Wegovy Dose vs Mounjaro Dose Comparison
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature for up to 6 weeks once removed from refrigeration, while Mounjaro only tolerates 21 days at room temperature. This storage advantage becomes particularly important when considering the Wegovy dose vs Mounjaro dose scheduling over months of treatment, as travel and lifestyle flexibility matter for long-term adherence. The FlexTouch pen design provides precise dose delivery with clear dose escalation markings, making it easy to verify you're administering the correct weekly injection. Store your Wegovy pens in the refrigerator at 2-8°C before first use, and never freeze or shake the medication, as this can damage the semaglutide protein structure. Each pen contains 4 doses, clearly marked for the once-weekly injection schedule that fits seamlessly into your routine.
Next Day Delivery Cold-Chain Logistics for Wegovy vs Mounjaro
Temperature control during delivery presents unique challenges when comparing Wegovy dose vs Mounjaro dose logistics, as both medications require consistent cold-chain maintenance to preserve their protein-based active ingredients. Our specialist pharmaceutical courier network uses validated cold-boxes with temperature monitoring throughout transit, ensuring your medication arrives within the required 2-8°C range regardless of external weather conditions. Each delivery includes temperature-sensitive strips that change colour if the medication has been exposed to harmful temperatures during transport.
The Wegovy dose vs Mounjaro dose delivery comparison shows identical cold-chain requirements, but different stability profiles once received - Wegovy's 6-week room temperature tolerance provides greater peace of mind for patients concerned about brief storage lapses. Our courier tracking system provides real-time updates from dispatch to delivery, with SMS notifications when your medication is out for delivery and requires signature. This reliability becomes essential when managing the precise timing requirements of weekly injections and dose escalations.
Complete Wegovy Dose vs Mounjaro Dose Treatment Planning
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which dosing protocol aligns best with your medical history and weight management objectives. The Wegovy dose schedule spans 16 weeks to reach maintenance, while Mounjaro's tirzepatide protocol follows a different timeline - both require commitment to the full escalation process for optimal results. Consider your lifestyle factors, injection preferences, and storage capabilities when discussing options during your clinical assessment. Our pharmacy team at GPhC registration #9012878 provides ongoing support throughout your treatment journey, whether you choose the semaglutide or tirzepatide pathway. Start your clinical assessment today and receive your prescribed medication via next day delivery, using code FIRST40 for new customers or DOSE25 for returning patients at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
